Literature DB >> 16091899

Transregional spread of a single clone of methicillin-resistant Staphylococcus aureus between groups of drug users in Switzerland.

F Fleisch1, E C Oechslin, A R Gujer, E Ritzler, A Imhof, C Ruef, W H Reinhart.   

Abstract

BACKGROUND: An epidemic spread of methicillin-resistant Staphylococcus aureus (MRSA) among intravenous drug users (IDUs) has been observed in Zurich. In the present study we investigated the situation in the Grisons, Switzerland. PATIENTS AND METHODS: We screened IDUs and their caregivers in medical and socio-therapeutical institutions in the Grisons for MRSA. Nose swabs were used for bacterial culture and pulsed-field gel electrophoresis for MRSA genotyping.
RESULTS: A total of 191 nose swabs from 111 IDUs and 80 caregivers was analyzed. None of the caregivers was MRSA positive. Six IDUs were asymptomatic MRSA carriers (5.4%). They participated in the official heroin program (MRSA prevalence in this group 16%). The MRSA genotype was identical with the single clone found in IDUs in Zurich, strongly suggesting an epidemic spread. Decolonization was successful in two persons only. Persistence of MRSA in IDUs must therefore be assumed.
CONCLUSION: We conclude that a single clone of MRSA, found in IDUs in Zurich, has spread to a distant region of Switzerland. A rigorous infection control program in all institutions with IDUs is necessary to prevent a further spread of MRSA.

Entities:  

Mesh:

Year:  2005        PMID: 16091899     DOI: 10.1007/s15010-005-4149-6

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  7 in total

Review 1.  Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic.

Authors:  Michael Z David; Robert S Daum
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

2.  MRSA decolonization: success rate, risk factors for failure and optimal duration of follow-up.

Authors:  P Kohler; A Bregenzer-Witteck; G Rettenmund; S Otterbech; M Schlegel
Journal:  Infection       Date:  2012-07-11       Impact factor: 3.553

3.  Prevalence of USA300 colonization or infection and associated variables during an outbreak of community-associated methicillin-resistant Staphylococcus aureus in a marginalized urban population.

Authors:  Mark Gilbert; Judy Macdonald; Marie Louie; Dan Gregson; Kunyan Zhang; Sameer Elsayed; Kevin Laupland; Diane Nielsen; Virginia Wheeler; Tara Lye; John Conly
Journal:  Can J Infect Dis Med Microbiol       Date:  2007-11       Impact factor: 2.471

4.  Prevalence, risk factors, phenotypic and molecular characteristics for Staphylococcus aureus carriage in community-based drug users in Guangzhou, China.

Authors:  Yingying Wang; Jialing Lin; Junli Zhou; Zhigang Han; Zhenjiang Yao
Journal:  Antimicrob Resist Infect Control       Date:  2020-03-02       Impact factor: 4.887

5.  Antibiotic-resistant pathogens in different patient settings and identification of surveillance gaps in Switzerland - a systematic review.

Authors:  R Fulchini; W C Albrich; A Kronenberg; A Egli; C R Kahlert; M Schlegel; P Kohler
Journal:  Epidemiol Infect       Date:  2019-08-30       Impact factor: 2.451

6.  Variability in SCCmecN1 spreading among injection drug users in Zurich, Switzerland.

Authors:  Miriam Ender; Brigitte Berger-Bächi; Nadine McCallum
Journal:  BMC Microbiol       Date:  2007-07-02       Impact factor: 3.605

7.  Appropriateness of antibiotic treatment in intravenous drug users, a retrospective analysis.

Authors:  Dominik Mertz; Nina Viktorin; Marcel Wolbers; Gerd Laifer; Bernd Leimenstoll; Ursula Fluckiger; Manuel Battegay
Journal:  BMC Infect Dis       Date:  2008-04-03       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.